• Home
  • Sitemap
  • Help
  • Technical Support
  • Contact
Toolbar - View Selection
 
Items 1 of 1
ALX-801-003 Revised 21-Dec-06
Monoclonal Antibody to P-glycoprotein (human) (C494)
Add to Clipboard
SYNONYMS anti-ABCB1 (human) MAb (C494)
anti-CD243 (human) MAb (C494)
PRODUCT LINE Cancer
PRODUCT CATEGORY P-glycoprotein [Pgp]/Related Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-801-003-C100   100 µg 790.00 USD Add To Cart
Product Specification
SPECIES CROSSREACTIVITY:
Human
CLONE: C494
ISOTYPE: Mouse IgG2a
SOURCE/HOST: Mouse ascites.
CONCENTRATION: ~0.1mg/ml
FORMULATION: Liquid. In 0.01M PBS containing 1% BSA and 0.1% sodium azide.
IMMUNOGEN: SDS-solubilized plasma membranes of an MDR (multidrug resistant) Chinese hamster ovary cell line and a human leukemic cell line.
SPECIFICITY: Recognizes a gene-specific, internal cellular epitope present only on the human MDR1 isoform of P-glycoprotein. Does not cross-react with human MDR3 P-glycoprotein.
CROSSREACTIVITY PROTEINS: Cross-reacts with pyruvate carboxylase (PC), an abundant mitochondrial enzyme. Unequivocal plasma membrane patterns of immunostaining represent true P-glycoprotein expression. Weak homogeneous, cytoplasmic or granular patterns of reactivity may represent staining of the PC cross-reactive epitope rather than positive staining for P-glycoprotein.
APPLICATION: Flow cytometry (cell permeabilization required):
Tissue culture cell lines, blood or bone marrow may be used. Specimens should be fixed in 3.7% formaldehyde for 10 minutes at room temperature to permeabilize the cell membrane. Incubation with approximately 5-10µg of antibody per 1x106 cells for 30-60 minutes at 4°C is suggested. Secondary antibodies (such as FITC-labelled anti-mouse IgG antibodies) available from commercial suppliers may be used for the subsequent steps, but should be titered in order to optimize the particular protocol in use.

Immunocytochemistry (cytospin preparations),
Immunohistochemistry (frozen sections, paraffin sections):
Adherent cells grown on coverslips or glass slides, cytospin preparations, frozen sections or paraffin-embedded materials may be used. Permeabilization of the cell membrane is a pre-requisite for exposing the epitope recognized by C494.
Frozen sections of cytospin should be air-dried and fixed in acetone for 10 minutes at -20°C.
Paraffin sections should be deparaffinized and rehydrated by conventional means. Secondary antibodies and fluorescent or histochemical detection systems available from other suppliers should be titered for optimal staining. Primary antibody may be diluted to >1:25 for biotin based detection systems. For optimal staining the primary antibody shold be incubated 20-60 minutes at room temperature.

Immunoprecipitation:
The C494 MAb can be used to immunoprecipitate P-glycoprotein from lysates of metabolically or surface radiolabelled cells.

Western Blot:
Protein concentration of specimens used should be in the range of  50-150µg per 50µl. There are many commercially available systems which may be used for direct Western blot. The MAb antibody should be used at a concentration of 1-10µl/ml in indirect Western blots. Exact concentration of antibody and incubation time will vary depending on the particular system used.

Optimal conditions must be determined individually for each application.

SHIPPING: SHIPPED ON BLUE ICE
SHORT TERM STORAGE: +4°C
LONG TERM STORAGE: -20°C
HANDLING: Avoid freeze/thaw cycles. After opening, prepare aliquots and store at -70°C.
Product Specific Literature References
Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies: N. Kartner, et al.; Nature 316, 820 (1985) Abstract
Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies: E. Georges, et al.; PNAS 87, 152 (1990) Abstract; Full Text
Comparison of an immunoperoxidase "sandwich" staining method and western blot detection of P-glycoprotein in human cell lines and sarcomas: K. Toth, et al.; Am. J. Pathol. 140, 1009 (1992) Abstract
MDR1 gene-specific monoclonal antibody C494 cross-reacts with pyruvate carboxylase: V.V. Rao, et al.; Cancer Res. 54, 1536 (1994) Abstract
Detection of P-glycoprotein in frozen and paraffin-embedded gastric adenocarcinoma tissues using a panel of monoclonal antibodies: F.J. Lacueva, et al.; Histopathology 32, 328 (1998) Abstract
Multidrug resistance phenotype in high grade soft tissue sarcoma: correlation of P-glycoprotein immunohistochemistry with pathologic response to chemotherapy: R.E. Jimenez, et al.; Cancer 86, 976 (1999) Abstract
Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier: V.V. Rao, et al.; PNAS 96, 3900 (1999) Abstract; Full Text
Multidrug resistance-1 and p-glycoprotein in human chondrosarcoma cell lines: expression correlates with decreased intracellular doxorubicin and in vitro chemoresistance: J.J. Wyman, et al.; J. Orthop. Res. 17, 935 (1999) Abstract
Expression of P-glycoprotein in hepatocellular carcinoma. A determinant of chemotherapy response: I.O. Ng, et al.; Am. J. Clin. Pathol. 113, 355 (2000) Abstract
Activation of the human P-glycoprotein ATPase by trypsin: S.L. Nuti, et al.; Biochemistry 39, 3423 (2000) Abstract
Up-regulation of drug resistance-related vaults during dendritic cell development: A.B. Schroeijers, et al.; J. Immunol. 168, 1572 (2002) Abstract
Further Categories Containing This Product:
Tumor MarkersCD AntibodiesMonoclonal Antibodies
 
 

Your items will be kept only for the duration of your visit.